This is to assist the long term care pharmacist in depleting stock that was prepared in blister packs during the shortage period. As these products are exactly the same as their brand name counterparts, Pharmacare will not provide special authorizations for brand name Cardizem7 or Isoptin7. While RBP has been very successful, many special authority requests were received for the more expensive agents when only one other product had been tried. Considering this huge variation in cost with little documented difference in efficacy between the numerous agents available, Pharmacare was not in a position to continue to routinely fund the more costly preparations. The physician is asked to specify the diagnosis on the special authority form.
S are exempt from the special authority process.
Please note that ketorolac, naproxen sodium, diclofenac rapide and etodolac remain as non-benefits and are not eligible for special authorization. We wish to provide clarification of the prioritization of special authorization requests. Requests requiring clarification or additional information may take longer to process than the above guidelines. Each request is assessed on an individual basis, based upon the information provided by the physician. However, please note that not all medications are eligible for coverage through the special authorization process.